Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.03 billion. The enterprise value is $1.35 billion.
Important Dates
The next confirmed earnings date is Tuesday, May 6, 2025, before market open.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.12 million shares outstanding. The number of shares has increased by 1.37% in one year.
| Current Share Class | 84.12M |
| Shares Outstanding | 84.12M |
| Shares Change (YoY) | +1.37% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 98.70% |
| Float | 83.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.96 |
| PS Ratio | 0.51 |
| Forward PS | 0.54 |
| PB Ratio | 1.35 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.59 |
| P/OCF Ratio | 5.00 |
| PEG Ratio | 0.84 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.23, with an EV/FCF ratio of 7.29.
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | 6.23 |
| EV / EBIT | 7.33 |
| EV / FCF | 7.29 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.47 |
| Quick Ratio | 1.43 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 2.69 |
| Debt / FCF | 3.59 |
| Interest Coverage | 4.51 |
Financial Efficiency
Return on equity (ROE) is -12.28% and return on invested capital (ROIC) is 7.71%.
| Return on Equity (ROE) | -12.28% |
| Return on Assets (ROA) | 5.25% |
| Return on Invested Capital (ROIC) | 7.71% |
| Return on Capital Employed (ROCE) | 10.69% |
| Revenue Per Employee | $488,573 |
| Profits Per Employee | -$24,046 |
| Employee Count | 4,120 |
| Asset Turnover | 0.92 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.27M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.88% in the last 52 weeks. The beta is 1.33, so MD's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +35.88% |
| 50-Day Moving Average | 14.18 |
| 200-Day Moving Average | 12.62 |
| Relative Strength Index (RSI) | 34.88 |
| Average Volume (20 Days) | 635,922 |
Short Selling Information
The latest short interest is 1.86 million, so 2.21% of the outstanding shares have been sold short.
| Short Interest | 1.86M |
| Short Previous Month | 2.77M |
| Short % of Shares Out | 2.21% |
| Short % of Float | 2.23% |
| Short Ratio (days to cover) | 2.54 |
Income Statement
In the last 12 months, MD had revenue of $2.01 billion and -$99.07 million in losses. Loss per share was -$1.19.
| Revenue | 2.01B |
| Gross Profit | 454.34M |
| Operating Income | 183.68M |
| Pretax Income | -267.92M |
| Net Income | -99.07M |
| EBITDA | 215.91M |
| EBIT | 183.68M |
| Loss Per Share | -$1.19 |
Full Income StatementBalance Sheet
The company has $348.51 million in cash and $662.31 million in debt, giving a net cash position of -$313.81 million or -$3.73 per share.
| Cash & Cash Equivalents | 348.51M |
| Total Debt | 662.31M |
| Net Cash | -313.81M |
| Net Cash Per Share | -$3.73 |
| Equity (Book Value) | 764.94M |
| Book Value Per Share | 9.09 |
| Working Capital | 205.50M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $206.57 million and capital expenditures -$22.02 million, giving a free cash flow of $184.55 million.
| Operating Cash Flow | 206.57M |
| Capital Expenditures | -22.02M |
| Free Cash Flow | 184.55M |
| FCF Per Share | $2.19 |
Full Cash Flow StatementMargins
Gross margin is 22.57%, with operating and profit margins of 9.13% and -4.92%.
| Gross Margin | 22.57% |
| Operating Margin | 9.13% |
| Pretax Margin | -5.03% |
| Profit Margin | -4.92% |
| EBITDA Margin | 10.73% |
| EBIT Margin | 9.13% |
| FCF Margin | 9.17% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.37% |
| Shareholder Yield | -1.37% |
| Earnings Yield | -9.60% |
| FCF Yield | 17.88% |
Dividend DetailsAnalyst Forecast
The average price target for MD is $16.75, which is 36.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.75 |
| Price Target Difference | 36.51% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 2.50% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.54 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 7 |